Skip to content

Innate and adaptive immune cells in the tumor microenvironment.

文献信息

DOI10.1038/ni.2703
PMID24048123
期刊Nature immunology
影响因子27.6
JCR 分区Q1
发表年份2013
被引次数2295
关键词肿瘤微环境, 免疫细胞, T细胞, 免疫逃逸, 免疫治疗
文献类型Journal Article, Review
ISSN1529-2908
页码1014-22
期号14(10)
作者Thomas F Gajewski, Hans Schreiber, Yang-Xin Fu

一句话小结

本研究探讨了肿瘤细胞如何逃避宿主CD8(+) T细胞的免疫攻击,发现肿瘤微环境可分为两类:一类具有T细胞炎症表型,通过免疫抑制通路抵抗免疫攻击;另一类则缺乏这种表型,似乎通过免疫排斥或无知机制实现逃逸。这一发现为不同类型肿瘤的免疫治疗策略提供了重要依据,强调了针对肿瘤微环境特征实施个性化治疗的必要性。

在麦伴科研 (maltsci.com) 搜索更多文献

肿瘤微环境 · 免疫细胞 · T细胞 · 免疫逃逸 · 免疫治疗

摘要

大多数肿瘤细胞表达能够介导宿主CD8(+) T细胞识别的抗原。临床检测到的癌症必须已经逃避了抗肿瘤免疫反应才能得以逐渐生长。最近的研究表明,肿瘤逃逸可以根据肿瘤微环境的细胞和分子特征分为两大类。一类主要亚群显示出T细胞炎症表型,包含浸润的T细胞、广泛的趋化因子谱以及表明先天免疫激活的I型干扰素特征。这些肿瘤似乎通过免疫系统抑制通路的主导抑制效应抵抗免疫攻击。另一种主要表型缺乏这种T细胞炎症表型,似乎通过免疫系统的排斥或无知来抵抗免疫攻击。这两种主要的肿瘤微环境表型可能需要不同的免疫治疗干预,以实现最佳的治疗效果。

英文摘要

Most tumor cells express antigens that can mediate recognition by host CD8(+) T cells. Cancers that are detected clinically must have evaded antitumor immune responses to grow progressively. Recent work has suggested two broad categories of tumor escape based on cellular and molecular characteristics of the tumor microenvironment. One major subset shows a T cell-inflamed phenotype consisting of infiltrating T cells, a broad chemokine profile and a type I interferon signature indicative of innate immune activation. These tumors appear to resist immune attack through the dominant inhibitory effects of immune system-suppressive pathways. The other major phenotype lacks this T cell-inflamed phenotype and appears to resist immune attack through immune system exclusion or ignorance. These two major phenotypes of tumor microenvironment may require distinct immunotherapeutic interventions for maximal therapeutic effect.

麦伴智能科研服务

智能阅读回答你对文献的任何问题,帮助理解文献中的复杂图表和公式
定位观点定位某个观点在文献中的蛛丝马迹
加入知识库完成数据提取,报告撰写等更多高级知识挖掘功能

主要研究问题

  1. 在肿瘤微环境中,先天免疫细胞和适应性免疫细胞的相互作用如何影响肿瘤的免疫逃逸机制?
  2. 针对不同类型的肿瘤微环境,免疫治疗的策略如何根据先天和适应性免疫细胞的表现进行调整?
  3. 先天免疫细胞在肿瘤微环境中的作用是否会影响适应性免疫细胞的功能?如果会,具体机制是什么?
  4. 在肿瘤微环境中,是否存在特定的因子能够促进先天免疫细胞与适应性免疫细胞之间的合作?
  5. 不同的肿瘤类型中,先天免疫细胞和适应性免疫细胞的比例和活性差异对治疗效果有什么潜在影响?

核心洞察

研究背景和目的

肿瘤微环境中的免疫细胞在肿瘤的发生和发展中扮演着重要角色。肿瘤细胞通常表达抗原,可以被宿主的CD8+ T细胞识别。肿瘤能够持续生长的一个原因是它们逃避了抗肿瘤免疫反应。研究表明,肿瘤微环境的细胞和分子特征可以分为两大类:一种是T细胞浸润型,另一种是非T细胞浸润型。这项研究的目的是探讨这两种类型的肿瘤微环境及其对免疫治疗的影响。

主要方法/材料/实验设计

研究主要通过对人类肿瘤组织的免疫表型分析和小鼠模型的机制实验来进行。具体步骤如下:

Mermaid diagram

关键结果和发现

  1. 肿瘤微环境的免疫表型

    • T细胞浸润型肿瘤表现出活化的CD8+ T细胞和多种趋化因子的表达,通常与良好的预后相关。
    • 非T细胞浸润型肿瘤缺乏这种浸润,且通常具有更高的基质密度和抑制性免疫细胞。
  2. 免疫逃逸机制

    • T细胞浸润型肿瘤中的CD8+ T细胞虽然存在,但受到PD-L1、IDO等免疫抑制通路的抑制。
    • 非T细胞浸润型肿瘤则通过免疫排斥或无知机制逃避免疫监视。
  3. 临床相关性

    • T细胞浸润型肿瘤的存在可能作为免疫治疗反应的预测生物标志物。
    • T细胞浸润与临床预后之间存在显著关联。

主要结论/意义/创新性

研究揭示了肿瘤微环境中不同免疫表型的存在及其对免疫治疗的影响。T细胞浸润型肿瘤可能更适合于现有的免疫治疗策略,而非T细胞浸润型肿瘤可能需要新的干预措施来诱导免疫激活。这为未来的免疫治疗策略提供了重要的指导,强调了对肿瘤微环境特征的深入理解。

研究局限性和未来方向

  • 局限性

    • 本研究主要基于肿瘤组织样本和小鼠模型,缺乏大规模临床试验数据的支持。
    • 对不同肿瘤类型的免疫表型特征的普遍性需要进一步验证。
  • 未来方向

    • 进一步研究不同免疫表型的肿瘤在免疫治疗中的反应,以开发更有效的治疗策略。
    • 探索如何改变非T细胞浸润型肿瘤的微环境,以促进T细胞的浸润和活化。

参考文献

  1. Chemotherapy-induced genotoxic stress promotes sensitivity to natural killer cell cytotoxicity by enabling missing-self recognition. - Jason H Fine;Peter Chen;Aruz Mesci;David S J Allan;Stephan Gasser;David H Raulet;James R Carlyle - Cancer research (2010)
  2. Mechanisms of the antitumor activity of human Vγ9Vδ2 T cells in combination with zoledronic acid in a preclinical model of neuroblastoma. - Emma Di Carlo;Paola Bocca;Laura Emionite;Michele Cilli;Giuseppe Cipollone;Fabio Morandi;Lizzia Raffaghello;Vito Pistoia;Ignazia Prigione - Molecular therapy : the journal of the American Society of Gene Therapy (2013)
  3. GSK's antigen-specific cancer immunotherapy programme: pilot results leading to Phase III clinical development. - Vincent G Brichard;Diane Lejeune - Vaccine (2007)
  4. Roles of activated Src and Stat3 signaling in melanoma tumor cell growth. - Guilian Niu;Tammy Bowman;Mei Huang;Steve Shivers;Douglas Reintgen;Adil Daud;Alfred Chang;Alan Kraker;Richard Jove;Hua Yu - Oncogene (2002)
  5. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. - L Chen;S Ashe;W A Brady;I Hellström;K E Hellström;J A Ledbetter;P McGowan;P S Linsley - Cell (1992)
  6. Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer. - Kalyani Narra;Stefanie R Mullins;Hyung-Ok Lee;Brenda Strzemkowski-Brun;Kimberly Magalong;Victoria J Christiansen;Patrick A McKee;Brian Egleston;Steven J Cohen;Louis M Weiner;Neal J Meropol;Jonathan D Cheng - Cancer biology & therapy (2007)
  7. Densely granulated murine NK cells eradicate large solid tumors. - Rebecca B Liu;Boris Engels;Ainhoa Arina;Karin Schreiber;Elizabeth Hyjek;Andrea Schietinger;David C Binder;Eric Butz;Thomas Krausz;Donald A Rowley;Bana Jabri;Hans Schreiber - Cancer research (2012)
  8. Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastases. - Ping Yu;Youjin Lee;Yang Wang;Xiaojuan Liu;Sogyong Auh;Thomas F Gajewski;Hans Schreiber;Zhaoyang You;Campbell Kaynor;Xinzhong Wang;Yang-Xin Fu - Journal of immunology (Baltimore, Md. : 1950) (2007)
  9. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. - Shuang Wei;Ilona Kryczek;Linhua Zou;Ben Daniel;Pui Cheng;Peter Mottram;Tyler Curiel;Andrzej Lange;Weiping Zou - Cancer research (2005)
  10. Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells. - Luca Gattinoni;Steven E Finkelstein;Christopher A Klebanoff;Paul A Antony;Douglas C Palmer;Paul J Spiess;Leroy N Hwang;Zhiya Yu;Claudia Wrzesinski;David M Heimann;Charles D Surh;Steven A Rosenberg;Nicholas P Restifo - The Journal of experimental medicine (2005)

引用本文的文献

  1. Fragmented sleep accelerates tumor growth and progression through recruitment of tumor-associated macrophages and TLR4 signaling. - Fahed Hakim;Yang Wang;Shelley X L Zhang;Jiamao Zheng;Esma S Yolcu;Alba Carreras;Abdelnaby Khalyfa;Haval Shirwan;Isaac Almendros;David Gozal - Cancer research (2014)
  2. Intermittent hypoxia-induced changes in tumor-associated macrophages and tumor malignancy in a mouse model of sleep apnea. - Isaac Almendros;Yang Wang;Lev Becker;Frances E Lennon;Jiamao Zheng;Brittney R Coats;Kelly S Schoenfelt;Alba Carreras;Fahed Hakim;Shelley X Zhang;Ramon Farré;David Gozal - American journal of respiratory and critical care medicine (2014)
  3. New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape. - Deepak Mittal;Matthew M Gubin;Robert D Schreiber;Mark J Smyth - Current opinion in immunology (2014)
  4. Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients. - Wen-Chao Wu;Hong-Wei Sun;Hai-Tian Chen;Jing Liang;Xing-Juan Yu;Chong Wu;Zilian Wang;Limin Zheng - Proceedings of the National Academy of Sciences of the United States of America (2014)
  5. The two faces of IL-6 in the tumor microenvironment. - Daniel T Fisher;Michelle M Appenheimer;Sharon S Evans - Seminars in immunology (2014)
  6. A phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome. - Shoichi Hazama;Yusuke Nakamura;Hiroko Takenouchi;Nobuaki Suzuki;Ryouichi Tsunedomi;Yuka Inoue;Yoshihiro Tokuhisa;Norio Iizuka;Shigefumi Yoshino;Kazuyoshi Takeda;Hirokazu Shinozaki;Akira Kamiya;Hiroyuki Furukawa;Masaaki Oka - Journal of translational medicine (2014)
  7. Emerging immunologic biomarkers: setting the (TNM-immune) stage. - Janis M Taube - Clinical cancer research : an official journal of the American Association for Cancer Research (2014)
  8. Role of Exosomes Released by Dendritic Cells and/or by Tumor Targets: Regulation of NK Cell Plasticity. - Katrin S Reiners;Juliane Dassler;Christoph Coch;Elke Pogge von Strandmann - Frontiers in immunology (2014)
  9. Immune response and the tumor microenvironment: how they communicate to regulate gastric cancer. - Keunwook Lee;Hyekyung Hwang;Ki Taek Nam - Gut and liver (2014)
  10. Heterogeneity in immune responses: from populations to single cells. - Rahul Satija;Alex K Shalek - Trends in immunology (2014)

... (2285 更多 篇文献)


© 2025 MaltSci 麦伴科研 - 我们用人工智能技术重塑科研